Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Return on Equity (2016 - 2025)

Historic Return on Equity for ProPhase Labs (PRPH) over the last 15 years, with Q3 2025 value amounting to 0.87%.

  • ProPhase Labs' Return on Equity rose 11500.0% to 0.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87%, marking a year-over-year increase of 11500.0%. This contributed to the annual value of 0.14% for FY2024, which is 1300.0% down from last year.
  • Per ProPhase Labs' latest filing, its Return on Equity stood at 0.87% for Q3 2025, which was up 11500.0% from 0.48% recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Return on Equity registered a high of 0.87% during Q3 2025, and its lowest value of 0.37% during Q1 2024.
  • In the last 5 years, ProPhase Labs' Return on Equity had a median value of 0.04% in 2021 and averaged 0.09%.
  • Per our database at Business Quant, ProPhase Labs' Return on Equity tumbled by -6300bps in 2023 and then skyrocketed by 11500bps in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Return on Equity stood at 0.1% in 2021, then surged by 183bps to 0.28% in 2022, then tumbled by -210bps to 0.31% in 2023, then soared by 45bps to 0.17% in 2024, then soared by 615bps to 0.87% in 2025.
  • Its Return on Equity stands at 0.87% for Q3 2025, versus 0.48% for Q2 2025 and 0.5% for Q1 2025.